-2%
Moxifloxacin, a fourth-generation fluoroquinolone, acts by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV—enzymes vital for bacterial DNA replication, transcription, and repair. This dual mechanism prevents bacterial cell division and leads to cell death.
Moxif Ophthalmic Solution
Active Ingredient: Moxifloxacin Hydrochloride
Moxif Ophthalmic Solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Aerobic Gram-positive bacteria: Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri, Streptococcus pneumoniae, and Streptococcus viridans group.
Aerobic Gram-negative bacteria: Acinetobacter lwoffii, Haemophilus influenzae, Haemophilus parainfluenzae.
Other microorganisms: Chlamydia trachomatis.